Guarantor Infromation (Cash Flows) (Details) - USD ($) $ in Thousands	2 Months Ended	7 Months Ended	9 Months Ended
	Sep. 30, 2015	Aug. 14, 2015	Sep. 30, 2016
Cash flow from financing activities:
Cash and cash equivalents at beginning of period			$ 6,927
Cash and cash equivalents at end of period			12,147
Parent
Cash flow from financing activities:
Cash and cash equivalents at beginning of period			0
Cash and cash equivalents at end of period			0
Guarantors
Cash flow from financing activities:
Cash and cash equivalents at beginning of period			646
Cash and cash equivalents at end of period			1,266
Non-Guarantors
Cash flow from financing activities:
Cash and cash equivalents at beginning of period			6,281
Cash and cash equivalents at end of period			10,881
Predecessor
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities		$ 28,323
Cash flow from investing activities:
(Loans to) repayments from affiliates		0
Capital expenditures		(32,301)
Proceeds from derivative instruments		(8,263)
Proceeds from the sale of assets		646
Net cash used in investing activities		(39,918)
Cash flow from financing activities:
Loans from (repayments to) affiliates		0
Dividends to affiliates		0
Short-term debt borrowings		18,511
Revolving Facility borrowings		160,000
Revolving Facility reductions		(99,000)
Principal payments on long term debt		(89)
Purchase of treasury shares		(63)
Revolving Facility refinancing		(5,068)
Other		(3,499)
Net cash provided by (used in) financing activities		20,824
Repayments of Subordinated Debt		200,000	0
Proceeds from Issuance of Preferred Stock and Preference Stock		150,000	0
Net change in cash and cash equivalents		9,229
Effect of exchange rate changes on cash and cash equivalents		(1,746)
Cash and cash equivalents at beginning of period	$ 25,033	17,550
Cash and cash equivalents at end of period		25,033
Proceeds from Stock Options Exercised		32
Predecessor | Parent
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities		(4,017)
Cash flow from investing activities:
(Loans to) repayments from affiliates		36,204
Capital expenditures		0
Proceeds from derivative instruments		0
Proceeds from the sale of assets		0
Net cash used in investing activities		36,204
Cash flow from financing activities:
Loans from (repayments to) affiliates		21,343
Dividends to affiliates		0
Short-term debt borrowings		0
Revolving Facility borrowings		0
Revolving Facility reductions		0
Principal payments on long term debt		0
Purchase of treasury shares		(63)
Revolving Facility refinancing		0
Other		(3,499)
Net cash provided by (used in) financing activities		(32,187)
Repayments of Subordinated Debt		200,000
Proceeds from Issuance of Preferred Stock and Preference Stock		150,000
Net change in cash and cash equivalents		0
Effect of exchange rate changes on cash and cash equivalents		0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period		0
Proceeds from Stock Options Exercised		32
Predecessor | Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities		34,418
Cash flow from investing activities:
(Loans to) repayments from affiliates		(21,343)
Capital expenditures		(20,572)
Proceeds from derivative instruments		(7,595)
Proceeds from the sale of assets		397
Net cash used in investing activities		(49,113)
Cash flow from financing activities:
Loans from (repayments to) affiliates		(36,204)
Dividends to affiliates		0
Short-term debt borrowings		14,002
Revolving Facility borrowings		126,000
Revolving Facility reductions		(87,000)
Principal payments on long term debt		(89)
Purchase of treasury shares		0
Revolving Facility refinancing		(5,037)
Other		0
Net cash provided by (used in) financing activities		11,672
Repayments of Subordinated Debt		0
Proceeds from Issuance of Preferred Stock and Preference Stock		0
Net change in cash and cash equivalents		(3,023)
Effect of exchange rate changes on cash and cash equivalents		0
Cash and cash equivalents at beginning of period	2,480	5,503
Cash and cash equivalents at end of period		2,480
Proceeds from Stock Options Exercised		0
Predecessor | Non-Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities		25,632
Cash flow from investing activities:
(Loans to) repayments from affiliates		0
Capital expenditures		(11,729)
Proceeds from derivative instruments		(668)
Proceeds from the sale of assets		249
Net cash used in investing activities		(12,148)
Cash flow from financing activities:
Loans from (repayments to) affiliates		0
Dividends to affiliates		(27,710)
Short-term debt borrowings		4,509
Revolving Facility borrowings		34,000
Revolving Facility reductions		(12,000)
Principal payments on long term debt		0
Purchase of treasury shares		0
Revolving Facility refinancing		(31)
Other		0
Net cash provided by (used in) financing activities		(1,232)
Repayments of Subordinated Debt		0
Proceeds from Issuance of Preferred Stock and Preference Stock		0
Net change in cash and cash equivalents		12,252
Effect of exchange rate changes on cash and cash equivalents		(1,746)
Cash and cash equivalents at beginning of period	22,553	12,047
Cash and cash equivalents at end of period		22,553
Proceeds from Stock Options Exercised		0
Predecessor | Consolidating Entries and Eliminations
Cash flow from financing activities:
Proceeds from Stock Options Exercised		0
Successor
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	3,912		28,731
Cash flow from investing activities:
(Loans to) repayments from affiliates	0		0
Capital expenditures	(5,239)		(22,257)
Proceeds from derivative instruments	84		(1,171)
Proceeds from the sale of assets	542		685
Net cash used in investing activities	(4,613)		(22,743)
Cash flow from financing activities:
Loans from (repayments to) affiliates			0
Loans from (repayments to) affiliates	0
Dividends to affiliates	0
Short-term debt borrowings	(10,180)		503
Revolving Facility borrowings	22,000		40,000
Revolving Facility reductions	(21,000)		(41,000)
Principal payments on long term debt	(12)		(104)
Purchase of treasury shares	0		0
Revolving Facility refinancing	0		(922)
Other	(1,385)		0
Net cash provided by (used in) financing activities	(10,577)		(1,523)
Repayments of Subordinated Debt	0
Proceeds from Issuance of Preferred Stock and Preference Stock	0
Net change in cash and cash equivalents	(11,278)		4,465
Effect of exchange rate changes on cash and cash equivalents	(294)		755
Cash and cash equivalents at beginning of period	25,033		6,927
Cash and cash equivalents at end of period	13,461	25,033	12,147
Proceeds from Stock Options Exercised	0		0
Successor | Parent
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(6,367)		(9,568)
Cash flow from investing activities:
(Loans to) repayments from affiliates	0		0
Capital expenditures	0		0
Proceeds from derivative instruments	0		0
Proceeds from the sale of assets	0		0
Net cash used in investing activities	0		0
Cash flow from financing activities:
Loans from (repayments to) affiliates			9,568
Loans from (repayments to) affiliates	7,752
Dividends to affiliates	0
Short-term debt borrowings	0		0
Revolving Facility borrowings	0		0
Revolving Facility reductions	0		0
Principal payments on long term debt	0		0
Revolving Facility refinancing			0
Other	(1,385)
Net cash provided by (used in) financing activities	6,367		9,568
Net change in cash and cash equivalents	0		0
Effect of exchange rate changes on cash and cash equivalents	0		0
Cash and cash equivalents at beginning of period	0		0
Cash and cash equivalents at end of period	0	0	0
Successor | Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(212)		19,207
Cash flow from investing activities:
(Loans to) repayments from affiliates	(7,752)		(9,568)
Capital expenditures	(2,136)		(7,453)
Proceeds from derivative instruments	0		0
Proceeds from the sale of assets	486		458
Net cash used in investing activities	(9,402)		(16,563)
Cash flow from financing activities:
Loans from (repayments to) affiliates			0
Loans from (repayments to) affiliates	0
Dividends to affiliates	0
Short-term debt borrowings	(5,699)		3
Revolving Facility borrowings	22,000		35,000
Revolving Facility reductions	(9,000)		(36,000)
Principal payments on long term debt	(12)		(104)
Revolving Facility refinancing			(922)
Other	0
Net cash provided by (used in) financing activities	7,289		(2,023)
Net change in cash and cash equivalents	(2,325)		621
Effect of exchange rate changes on cash and cash equivalents	0		0
Cash and cash equivalents at beginning of period	2,480		646
Cash and cash equivalents at end of period	155	2,480	1,267
Successor | Non-Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	10,491		19,092
Cash flow from investing activities:
(Loans to) repayments from affiliates	0		0
Capital expenditures	(3,103)		(14,804)
Proceeds from derivative instruments	84		(1,171)
Proceeds from the sale of assets	56		227
Net cash used in investing activities	(2,963)		(15,748)
Cash flow from financing activities:
Loans from (repayments to) affiliates			0
Loans from (repayments to) affiliates	0
Dividends to affiliates	0
Short-term debt borrowings	(4,481)		500
Revolving Facility borrowings	0		5,000
Revolving Facility reductions	(12,000)		(5,000)
Principal payments on long term debt	0		0
Revolving Facility refinancing			0
Other	0
Net cash provided by (used in) financing activities	(16,481)		500
Net change in cash and cash equivalents	(8,953)		3,844
Effect of exchange rate changes on cash and cash equivalents	(294)		755
Cash and cash equivalents at beginning of period	22,553		6,281
Cash and cash equivalents at end of period	13,306	22,553	10,880
Consolidating Entries and Eliminations
Cash flow from financing activities:
Cash and cash equivalents at beginning of period			0
Cash and cash equivalents at end of period			0
Consolidating Entries and Eliminations | Predecessor
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities		(27,710)
Cash flow from investing activities:
(Loans to) repayments from affiliates		(14,861)
Capital expenditures		0
Proceeds from derivative instruments		0
Proceeds from the sale of assets		0
Net cash used in investing activities		(14,861)
Cash flow from financing activities:
Loans from (repayments to) affiliates		14,861
Dividends to affiliates		27,710
Short-term debt borrowings		0
Revolving Facility borrowings		0
Revolving Facility reductions		0
Principal payments on long term debt		0
Purchase of treasury shares		0
Revolving Facility refinancing		0
Other		0
Net cash provided by (used in) financing activities		42,571
Repayments of Subordinated Debt		0
Proceeds from Issuance of Preferred Stock and Preference Stock		0
Net change in cash and cash equivalents		0
Effect of exchange rate changes on cash and cash equivalents		0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period		0
Consolidating Entries and Eliminations | Successor
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0		0
Cash flow from investing activities:
(Loans to) repayments from affiliates	7,752		9,568
Capital expenditures	0		0
Proceeds from derivative instruments	0		0
Proceeds from the sale of assets	0		0
Net cash used in investing activities	7,752		9,568
Cash flow from financing activities:
Loans from (repayments to) affiliates			(9,568)
Loans from (repayments to) affiliates	(7,752)
Dividends to affiliates	0
Short-term debt borrowings	0		0
Revolving Facility borrowings	0		0
Revolving Facility reductions	0		0
Principal payments on long term debt	0		0
Revolving Facility refinancing			0
Other	0
Net cash provided by (used in) financing activities	(7,752)		(9,568)
Net change in cash and cash equivalents	0		0
Effect of exchange rate changes on cash and cash equivalents	0		0
Cash and cash equivalents at beginning of period	0		0
Cash and cash equivalents at end of period	$ 0	$ 0	$ 0